Genome editing in pathogenic organisms refers to the targeted modification of the genetic material of these organisms with the goal of better understanding their biology, developing new therapeutic strategies, or creating attenuated strains for vaccine development. This field has seen significant advancements in recent years, with the development of various genome-editing tools.
Genomic editing tools like CRISPR-Cas9 have revolutionized the field by providing efficient and precise methods for modifying various genomes. The genome editing approach is not restricted to just pathogen, but even to their carrier vectors. With advancement in knowledge and technology, genome editing is stepping beyond just CRISPR-Cas9 and we thus need to ponder on these advances. It is also time to acknowledge the risks involved in the genome editing, paving way for more cautious strategy development to handle pathogens.
Genomic editing in pathogens holds immense potential for various applications, with the overall goal being to manipulate their genetic makeup for specific purposes. This manipulation can involve:
- Modifying existing genes: Editing specific genes within the pathogen’s genome to be used for:
o Curing infectious and non-infectious diseases
o Improve product production: Enhance microorganisms' ability to produce valuable substances like biofuels, enzymes, or pharmaceuticals.
o Create novel functionalities: Engineer microorganisms to perform new tasks, such as degrading pollutants or cleaning wastewater.
o Develop new vaccines and medicines: Modify microorganisms to produce vaccines or drug precursors directly.
- Introducing new genes: Integrating new genes into the microorganism's genome can equip it with entirely new capabilities. This can be used to:
o Enhance environmental remediation: Design microorganisms to break down environmental pollutants or combat climate change.
o Develop next-generation probiotics: Improve the health benefits of probiotic bacteria or engineer them to deliver therapeutic molecules.
o Create novel biosensors: Develop microorganisms that can detect specific environmental changes or pathogens.
o Engineering E. coli bacteria to produce biofuels more efficiently.
o Modifying yeast strains for improved beer and wine fermentation.
o Developing genetically modified probiotics that can treat gastrointestinal diseases.
o Designing bacteria that can clean up oil spills or heavy metal contamination.
Here are some potential themes based on different areas of interest:
Theme 1: Development and Optimization of Editing Tools:
- Explore alternative or novel editing tools beyond CRISPR-Cas9.
- Develop methods for efficient delivery of editing tools into specific microorganisms.
Theme 2: Successful genome edits in pathogens leading to potential therapeutics and treatment strategies.
Theme 3: Understanding the Impact of Edits in Pathogens:
- Develop predictive models to understand the potential outcomes of specific edits.
- Investigate potential unintended consequences and off-target effects of editing.
Theme 4: Translating Research into Applications:
- Develop practical applications of microbial genomic editing in various fields such as biofuel production, environmental remediation, medicine, and food and nutrition technology.
- Evaluate the economic and environmental feasibility of using genetically modified microorganisms.
Theme 5: Genome editing technologies: Pioneering Disease Resistance in Prokaryotic and Eukaryotic worlds.
Keywords:
Pathogen, Genome-editing, infectious diseases, Therapeutics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Genome editing in pathogenic organisms refers to the targeted modification of the genetic material of these organisms with the goal of better understanding their biology, developing new therapeutic strategies, or creating attenuated strains for vaccine development. This field has seen significant advancements in recent years, with the development of various genome-editing tools.
Genomic editing tools like CRISPR-Cas9 have revolutionized the field by providing efficient and precise methods for modifying various genomes. The genome editing approach is not restricted to just pathogen, but even to their carrier vectors. With advancement in knowledge and technology, genome editing is stepping beyond just CRISPR-Cas9 and we thus need to ponder on these advances. It is also time to acknowledge the risks involved in the genome editing, paving way for more cautious strategy development to handle pathogens.
Genomic editing in pathogens holds immense potential for various applications, with the overall goal being to manipulate their genetic makeup for specific purposes. This manipulation can involve:
- Modifying existing genes: Editing specific genes within the pathogen’s genome to be used for:
o Curing infectious and non-infectious diseases
o Improve product production: Enhance microorganisms' ability to produce valuable substances like biofuels, enzymes, or pharmaceuticals.
o Create novel functionalities: Engineer microorganisms to perform new tasks, such as degrading pollutants or cleaning wastewater.
o Develop new vaccines and medicines: Modify microorganisms to produce vaccines or drug precursors directly.
- Introducing new genes: Integrating new genes into the microorganism's genome can equip it with entirely new capabilities. This can be used to:
o Enhance environmental remediation: Design microorganisms to break down environmental pollutants or combat climate change.
o Develop next-generation probiotics: Improve the health benefits of probiotic bacteria or engineer them to deliver therapeutic molecules.
o Create novel biosensors: Develop microorganisms that can detect specific environmental changes or pathogens.
o Engineering E. coli bacteria to produce biofuels more efficiently.
o Modifying yeast strains for improved beer and wine fermentation.
o Developing genetically modified probiotics that can treat gastrointestinal diseases.
o Designing bacteria that can clean up oil spills or heavy metal contamination.
Here are some potential themes based on different areas of interest:
Theme 1: Development and Optimization of Editing Tools:
- Explore alternative or novel editing tools beyond CRISPR-Cas9.
- Develop methods for efficient delivery of editing tools into specific microorganisms.
Theme 2: Successful genome edits in pathogens leading to potential therapeutics and treatment strategies.
Theme 3: Understanding the Impact of Edits in Pathogens:
- Develop predictive models to understand the potential outcomes of specific edits.
- Investigate potential unintended consequences and off-target effects of editing.
Theme 4: Translating Research into Applications:
- Develop practical applications of microbial genomic editing in various fields such as biofuel production, environmental remediation, medicine, and food and nutrition technology.
- Evaluate the economic and environmental feasibility of using genetically modified microorganisms.
Theme 5: Genome editing technologies: Pioneering Disease Resistance in Prokaryotic and Eukaryotic worlds.
Keywords:
Pathogen, Genome-editing, infectious diseases, Therapeutics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.